News

NIH is now accepting requests for human embryonic stem cell lines to be approved for use in NIH-funded research.

OGI launches of a new program focused on genomics technology service platforms in Ontario, with six partnered service platforms on board.

Fluidigm Europe has announced the availability of a new customer technical poster** entitled 'Comprehensive profiling of microRNAs in murine hematopoietic stem cells using a microfluidics approach' that reports upon the pioneering work of researchers at the BC Cancer Agency and University of British Columbia (Vancouver, Canada).

The Medical Research Council (MRC) sets the record straight following concerns about the level of investment in hybrid stem cell research, raised on the front page of today’s Independent.

The Riverside Company, has acquired Crioestaminal, a company that isolates and cryopreserves stem cells from umbilical cord blood.

The ease and security of automation is coming to bone marrow stromal cell expansion in a new machine in the National Institutes of Health Clinical Center's Department of Transfusion Medicine. Reducing the current manual method guarantees less contamination and frees staff time for other procedures.

StemCells, Inc. today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development.

StemCells Inc. announced that it has entered into an agreement with the University of California, San Francisco (UCSF) Children’s Hospital to conduct the first ever neural stem cell clinical trial in a myelination disorder.

Joint prosthesis replaces small joints in the hand and foot and it has been tested clinically in rheumatoid arthritis patients. Tampere University Hospital, Hospital of Foundation of Rheumatoid Arthritis in Heinola and clinics in Germany and Italy participated these international clinical trials.

The master gene that causes blood stem cells to turn into disease-fighting 'Natural Killer' (NK) immune cells has been identified by scientists, in a study published in Nature Immunology today.